Achilles Therapeutics plc
Achilles Therapeutics plc (ACHL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
achl · stock forecast · 5 analysts (3M) · FMP · updated Nov 19, 2025
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.00
Consensus
$2.00
+35.1% upside
Low
$2.00
Median: $2 · Last Close: $1.48
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.54 | ↑ 3.86% |
1-day model range: $1.53–$1.54. Peak: $1.54 (+3.86%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -12.0% |
| 2028 | $1 | -17.3% |
| 2029 | $1 | -19.8% |
| 2030 | $1 | -21.0% |
| 2031 | — | -21.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACHL · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-04-05 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2024-04-05 | Chardan Capital | Maintains | Buy→Buy |
| 2023-12-14 | B of A Securities | Downgrade ↓ | Buy→Underperform |
| 2023-08-07 | Chardan Capital | Maintains | Buy→Buy |
| 2023-08-06 | Chardan Capital | Maintains | Buy→Buy |
| 2023-05-11 | Chardan Capital | Maintains | Buy→Buy |
| 2023-05-10 | Chardan Capital | Maintains | Buy→Buy |
| 2022-12-07 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-12-07 | Chardan Capital | Maintains | Buy→Buy |
| 2022-12-06 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Achilles Therapeutics plc (ACHL) stock. Of the recent 16 rating actions, 0 were upgrades and 2 were downgrades. 5 analysts currently cover ACHL.
Analyst Recommendation Trends
ACHL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-0.18
EPS Next Year
$-0.12
↓ 33.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACHL EPS of $-0.18 for the current fiscal year, based on estimates from 1 analysts. The ACHL revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ACHL stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACHL price target is $2.00 (+35.1% upside), with an analyst consensus of Buy.
The ACHL short-term stock prediction for tomorrow is $1.54 (+3.86%). The ACHL stock price prediction for 2027 estimates an average of $1. The ACHL stock prediction for 2030 projects a range of $1–$1.
Achilles Therapeutics plc trades on NASDAQ under the ticker ACHL. The ACHL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 40% of covering analysts.
Frequently asked questions
ACHL forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month ACHL price target is $2.00, with a high forecast of $2.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +35.1% potential upside from the current price of $1.48.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.